Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis.

Porteous DJ, Dorin JR, McLachlan G, Davidson-Smith H, Davidson H, Stevenson BJ, Carothers AD, Wallace WA, Moralee S, Hoenes C, Kallmeyer G, Michaelis U, Naujoks K, Ho LP, Samways JM, Imrie M, Greening AP, Innes JA.

Gene Ther. 1997 Mar;4(3):210-8.

2.

Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.

Lee TW, Southern KW, Perry LA, Penny-Dimri JC, Aslam AA.

Cochrane Database Syst Rev. 2016 Jun 17;(6):CD005599. doi: 10.1002/14651858.CD005599.pub5. Review.

PMID:
27314455
3.
4.

Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.

Lee TW, Southern KW.

Cochrane Database Syst Rev. 2013 Nov 26;(11):CD005599. doi: 10.1002/14651858.CD005599.pub4. Review. Update in: Cochrane Database Syst Rev. 2016;(6):CD005599.

PMID:
24282073
5.

Technology evaluation: cystic fibrosis therapy, Genzyme.

Cockett MI.

Curr Opin Mol Ther. 1999 Apr;1(2):279-83. Review.

PMID:
11715952
6.

[Gene therapy in mucoviscidosis].

Schatz C, Pavirani A.

Rev Pneumol Clin. 1995;51(3):201-6. Review. French.

PMID:
7569584
7.

Liposomes and viruses for gene therapy of cystic fibrosis.

Coutelle C, Williamson R.

J Aerosol Med. 1996 Spring;9(1):79-88. Review.

PMID:
10160212
8.

Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.

Lee TW, Southern KW.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD005599. doi: 10.1002/14651858.CD005599.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;11:CD005599.

PMID:
23076917
9.

Cationic lipid:pDNA complexes for the treatment of cystic fibrosis.

Eastman SJ, Scheule RK.

Curr Opin Mol Ther. 1999 Apr;1(2):186-96. Review.

PMID:
11715942
10.

Gene therapy for cystic fibrosis by means of aerosol.

Rochat T, Morris MA.

J Aerosol Med. 2002 Summer;15(2):229-35. Review.

PMID:
12184873
11.

Targeting the Root Cause of Cystic Fibrosis.

Trescott L, Holcomb J, Spellmon N, Mcleod C, Aljehane L, Sun F, Li C, Yang Z.

Curr Drug Targets. 2015;16(9):933-44. Review.

PMID:
25316272
12.

Gene therapy in cystic fibrosis.

Flotte TR, Laube BL.

Chest. 2001 Sep;120(3 Suppl):124S-131S. Review.

PMID:
11555567
13.

Gene therapy for the respiratory manifestations of cystic fibrosis.

Korst RJ, McElvaney NG, Chu CS, Rosenfeld MA, Mastrangeli A, Hay J, Brody SL, Eissa NT, Danel C, Jaffe HA, et al.

Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 2):S75-87. Review.

PMID:
7533609
14.

Delivery of genes into the CF airway.

Gill DR, Hyde SC.

Thorax. 2014 Oct;69(10):962-4. doi: 10.1136/thoraxjnl-2014-205835. Epub 2014 Jul 11. Review.

PMID:
25015239
15.

Is gene therapy in cystic fibrosis a realistic expectation?

McElvaney NG.

Curr Opin Pulm Med. 1996 Nov;2(6):466-71. Review.

PMID:
9363187
16.

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis.

Alton EWFW, Armstrong DK, Ashby D, Bayfield KJ, Bilton D, Bloomfield EV, Boyd AC, Brand J, Buchan R, Calcedo R, Carvelli P, Chan M, Cheng SH, Collie DS, Cunningham S, Davidson HE, Davies G, Davies JC, Davies LA, Dewar MH, Doherty A, Donovan J, Dwyer NS, Elgmati HI, Featherstone RF, Gavino J, Gea-Sorli S, Geddes DM, Gibson JSR, Gill DR, Greening AP, Griesenbach U, Hansell DM, Harman K, Higgins TE, Hodges SL, Hyde SC, Hyndman L, Innes JA, Jacob J, Jones N, Keogh BF, Limberis MP, Lloyd-Evans P, Maclean AW, Manvell MC, McCormick D, McGovern M, McLachlan G, Meng C, Montero MA, Milligan H, Moyce LJ, Murray GD, Nicholson AG, Osadolor T, Parra-Leiton J, Porteous DJ, Pringle IA, Punch EK, Pytel KM, Quittner AL, Rivellini G, Saunders CJ, Scheule RK, Sheard S, Simmonds NJ, Smith K, Smith SN, Soussi N, Soussi S, Spearing EJ, Stevenson BJ, Sumner-Jones SG, Turkkila M, Ureta RP, Waller MD, Wasowicz MY, Wilson JM, Wolstenholme-Hogg P; on behalf of the UK Cystic Fibrosis Gene Therapy Consortium.

Southampton (UK): NIHR Journals Library; 2016 Jul.

17.

Cystic Fibrosis Gene Therapy in the UK and Elsewhere.

Griesenbach U, Pytel KM, Alton EW.

Hum Gene Ther. 2015 May;26(5):266-75. doi: 10.1089/hum.2015.027. Review.

18.

New horizons for cystic fibrosis treatment.

Fajac I, De Boeck K.

Pharmacol Ther. 2017 Feb;170:205-211. doi: 10.1016/j.pharmthera.2016.11.009. Epub 2016 Dec 1. Review.

PMID:
27916649
19.

Genetic therapies for cystic fibrosis lung disease.

Sinn PL, Anthony RM, McCray PB Jr.

Hum Mol Genet. 2011 Apr 15;20(R1):R79-86. doi: 10.1093/hmg/ddr104. Epub 2011 Mar 21. Review.

20.

Gene therapy in cystic fibrosis.

Armstrong DK, Cunningham S, Davies JC, Alton EW.

Arch Dis Child. 2014 May;99(5):465-8. doi: 10.1136/archdischild-2012-302158. Epub 2014 Jan 24. Review.

PMID:
24464978

Supplemental Content

Support Center